UNITED STATES    
   

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

  SEC File Number 001-40001
    FORM 12b-25    
         
    NOTIFICATION OF LATE FILING  

CUSIP Number

204833 107

 

(Check One): Form 10-K Form 20-F Form 11-K Form 10-Q Form 10-D Form N-CEN Form N-CSR

 

For Period Ended: September 30, 2022

 

Transition Report on Form 10-K

Transition Report on Form 20-F

Transition Report on Form 11-K

Transition Report on Form 10-Q

Transition Report on N-SAR

For the Transition Period Ended:

 

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

 

Part I – Registrant Information

Full Name of Registrant:    
    Compute Health Acquisition Corp.
Former Name if Applicable:    
    Not applicable.
Address of Principal Executive Office    
(Street and Number):    
    1100 North Market Street, 4th Floor
City, State and Zip Code:    
    Wilmington, DE 19890

 

 

Part II – Rules 12b-25(b) and (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

(a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

 

(b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

(c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

 

 

Part III – Narrative

 

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

 

Compute Health Acquisition Corp. (the “Company”) has determined that it is unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2022 (the “Quarterly Report”) by the prescribed due date as a result of the fact that the compilation, dissemination and review of the information required to be presented in the Quarterly Report for the relevant period has imposed unexpected time constraints. The Company anticipates that it will file the Quarterly Report no later than the fifth calendar day following the prescribed due date.

 
Part IV – Other Information
 

 

(1) Name and telephone number of person to contact in regard to this notification

 

Joshua Fink (212) 829-3500
(Name) (Area Code) (Telephone Number)

 

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).

 

Yes No

 

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

 

Yes No

 

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

2

 

 

SIGNATURE

 

Compute Health Acquisition Corp. has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

  COMPUTE HEALTH ACQUISITION CORP.
   
  By: /s/ Joshua Fink
    Joshua Fink
    Co-Chief Executive Officer

Date: November 15, 2022

 

3